Symrise AG (FRA:SY1) has been given an average recommendation of “Hold” by the twenty-one analysts that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, thirteen have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is €73.94 ($85.97).
A number of research analysts have recently weighed in on the company. Hauck & Aufhaeuser set a €75.00 ($87.21) price objective on Symrise and gave the company a “neutral” rating in a research report on Friday, August 31st. Goldman Sachs Group set a €58.20 ($67.67) target price on shares of Symrise and gave the stock a “sell” rating in a research report on Monday, September 3rd. Morgan Stanley set a €75.00 ($87.21) target price on shares of Symrise and gave the stock a “neutral” rating in a research report on Wednesday, August 29th. UBS Group set a €73.00 ($84.88) price objective on shares of Symrise and gave the company a “neutral” rating in a report on Tuesday, August 14th. Finally, Kepler Capital Markets set a €70.00 ($81.40) price target on shares of Symrise and gave the stock a “neutral” rating in a report on Tuesday, August 14th.
Shares of FRA:SY1 traded down €0.06 ($0.07) during midday trading on Friday, hitting €69.72 ($81.07). The company had a trading volume of 194,869 shares. Symrise has a 12-month low of €56.96 ($66.23) and a 12-month high of €73.48 ($85.44).
Symrise Company Profile
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Recommended Story: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.